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Phosphopantetheinyl transferase (PptT) is an essential enzyme in Mycobacterium 
tuberculosis (Mtb) that adds a pantothenate group onto carrier proteins using coenzyme A 
(CoA), changing them from the apo to holo enzyme configuration. Encoded for in the same 
operon, phosphopantetheinyl hydrolase (PptH) is a newly identified enzyme that counterbalances 
this reaction by removing the pantetheine group from the holo-carrier protein, resulting in an 
apo-carrier protein. Because PptH appears to operate a futile cycle in the cell, its purpose 
remains unknown. In this project, I aimed to understand the functions of PptH and the conditions 
in which it becomes essential in the mycobacterial cell through a series of chemical stress tests 
and an analysis of binding partners of PptH. Select chemical stress growth assays indicated that 
Mycobacterium smegmatis (Msm) strains encoding putative PptH loss-of-function (LOF) 
mutations possess impaired cell wall integrity. CRISPRi was used to test for synthetic lethality in 
the proposed role of PptH in a CoA salvage pathway. Co-IPs were not able to show that PptH 
and its neighboring enzyme, PptT are binding partners. These results glean insight into 











List of Common Abbreviations: 
ATc (Anhydrotetracycline) 
ACP (Acyl carrier protein) 
CoA (Coenzyme A)  
Comp (Complement) 
CRISPRi (CRISPR interference) 
IP (Immunoprecipitation)  
kd (Knockdown) 
k/o (Knockout) 
LOD (Limit of Detection) 
LOF (Loss-of-Function)  
MIC (Minimum Inhibitory Concentration) 
Msm (Mycobacterium smegmatis)  
Mtb (Mycobacterium tuberculosis)  
OD (Optical Density) 
PAM (Protospacer adjacent motif) 
PBS (Phosphate-Buffered Saline)  
Ppt (Phosphopantetheine)  
PptH (Phosphopantetheinyl hydrolase) 
PptT (Phosphopantetheinyl transferase)  





ZOI (Zone of Inhibition)  
8918 (1-[(2,6-diethylphenyl)-3-N-ethylcarbamimodoyl] urea)  
Introduction 
Nearly one quarter of the world’s population is believed to be latently infected with 
Mycobacterium tuberculosis (Mtb) and tuberculosis (TB) is the primary driver of mortality from 
infectious disease (Houben & Dodd, 2016; “Tuberculosis (TB),” 2017). Mtb is inhaled in the 
form of aerosol droplets, where once established in the lungs, is consumed by macrophages that 
can distribute the bacteria throughout the body. The host immune system often responds by 
isolating Mtb in granulomas, where the bacteria are non-replicating and may remain dormant 
indefinitely. These people, who are latently infected with TB, are therefore asymptomatic and 
not infectious. Those whose immune system does not effectively contain the infection may 
experience a reactivation of Mtb, and the bacilli can spread to other organs (Barry et al., 2009). 
Risk factors for TB include conditions that are immunocompromising, such as diabetes and 
HIV/AIDS. Malnourishment resulting from excessive alcohol and non-injectable drug use, as 
well as homelessness, or residence in a correctional facility can also increase risk for TB 
infection (“Tuberculosis (TB),” 2018).  
The current drug regimen to treat tuberculosis involves six months of multi-drug 
antibiotic therapy, consisting of two months of daily treatment with rifampicin (RIF), 
pyrazinamide, ethambutol, and isoniazid (INH), followed by four months of daily treatment with 
RIF and INH (World Health Organization, 2010). However, many of the countries with the 
highest rates of TB lack the health infrastructure required for timely diagnosis, and people with 
the disease may not be able to secure a steady supply of drugs. Often, the full course of 
antibiotics is not completed due to a lack of consistent healthcare access, the early disappearance 
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of symptoms, or unpleasant side effects. As a result, emerging resistance to the standard drug 
regimen has become a major global problem, with 500,000 new cases of multidrug-resistant 
(MDR) and extensively drug-resistant (XDR) TB in 2016 reported by the CDC (“Tuberculosis 
(TB),” 2018). Drug-resistant TB can take up to 32 months to treat, and reduces the successful 
patient treatment rate to 50% (World Health Organization, 2010). There is a global need for new 
drug targets, as Mtb evolves resistance to current drugs.  
 
 
Fig. 1. PptT and PptH reaction mechanism. PptT removes Ppt from coenzyme A (CoA) and 
covalently attaches this group onto acyl carrier proteins (ACPs) (figure adapted from LeBlanc et 
al., 2012, Ballinger, 2018, and Nathan, 2018). PptH catalyzes the conversion of holo-ACPs to 
apo-ACPs through the removal of Ppt. The putative role of PptH in a CoA salvage pathway is 




Phosphopantetheinyl transferase (PptT) is currently under exploration as a drug target in 
Mtb and no drug-like inhibitors of PptT are known. In Mtb, rv2794c encodes for PptT, which 
charges ACPs for the synthesis of key structural lipids. PptT transfers a 4′-phosphopantetheine 
group onto carrier proteins such as polyketide synthases and fatty acid synthases using coenzyme 
A (CoA), changing them from the apo to holo enzyme configuration (Fig.1). This enzyme is 
essential in Mtb and the reaction it catalyzes is involved in the production of long-chain fatty 
acid cell wall lipids such as mycolic acids, and lipids that serve as virulence factors such as 
phthiocerol dimycocerosates (PDIMs) that modulate host immune reactions. PptT also catalyzes 
the biosynthesis of mycobactins that act as siderophores. Because the intrinsic drug resistance of 
Mtb is tied to its unusual, lipid-rich cell wall, PptT is an attractive drug target (LeBlanc et al., 
2012).  
PptT is the target of an amidino-urea compound identified in a high throughput screen 
with Sanofi, a collaborating pharmaceutical company. This mycobactericidal compound, named 
8918, inhibits PptT by binding in its active site. The structure of 8918 is shown below in Fig. 2. 
The minimum inhibitory concentration for 90% of bacterial growth (MIC90) of 8918 against 
H37Rv Mtb, a laboratory strain that is virulent in a mouse model, was determined to be 3.1 mM 
(Ballinger et al., 2019). Elaine Ballinger identified mutant Mtb colonies resistant to 8918. The 
majority of these mutants had a resistance conferring mutation that was a putative loss-of-
function (LOF) in the neighboring gene rv2795c, encoding the enzyme phosphopantetheinyl 
hydrolase (PptH). Further analysis of this enzyme elucidated a novel mechanism of resistance in 
Mycobacteria. Some resistant mutants also had mutations in pptT, although these mutations were 




Fig. 2. Structure of 8918 (1-[(2,6-diethylphenyl)-3-N-ethylcarbamimodoyl] urea): A 
mycobactericidal compound that targets PptT by binding in the Ppt binding site (figure adapted 
from Ballinger et al., 2019).  
Encoded for by rv2795c in Mtb, PptH is a metallophosphoesterase that removes the Ppt 
group from the holo-carrier proteins, resulting in apo-carrier proteins. PptH appears to 
counterbalance the activities of PptT, and operate a futile cycle as it has no obvious utility to the 
cell. Unlike PptT, PptH is not known to be essential to the cell under any conditions. This 
enzyme is similar in function to non-homologous acyl carrier protein (ACP) hydrolases, but was 
named PptH by the Nathan laboratory as it is a newly identified enzyme in Mtb. Like PptH, ACP 
hydrolases remove Ppt from ACPs in vitro, as demonstrated in Fig. 1 (Ballinger et al., 2019). 
Also similar to PptH, ACP hydrolase in E. coli performs hydrolysis and utilizes magnesium, 
although the two enzymes are not structurally homologous (Ballinger, 2018). The enzyme is 
highly conserved in Mycobacteria, as orthologous genes to rv2795c exist in M. smegmatis 
(Msm), M. leprae, M. bovis, and M. marinum (Mycobrowser, 2018). The retention of PptH in M. 
leprae is noteworthy, as the genome of this species is highly reduced, thus implying a significant 
function for PptH (Ballinger et al., 2019).  
In this report, I aimed to understand the conditions in which PptH becomes essential so as 
to determine its physiological functions. Because LOF of PptH leads to resistance to PptT 
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inhibitor compound 8918 and PptT is involved in cell wall formation, I hypothesized that PptH 
may be involved in cell wall integrity. To test cell wall viability, I designed a series of stress tests 
with chemicals known to target the mycobacterial cell wall or represent the conditions that Mtb 
encounters in the human macrophage. Chemical stress tests were completed with wild type (WT) 
and putative PptH LOF mutant Msm strains. Msm is a fast-growing species of Mycobacteria that 
is non-pathogenic to humans. 
Beyond involvement in cell wall integrity, I hypothesized that PptH was involved in a 
CoA salvage pathway, as elucidated in Fig. 1. By removing the phosphopantetheine group from 
holo-carrier proteins, PptH activity releases free pools of Ppt, which is the precursor for 
Coenzyme A. It may be energetically advantageous for the cell to not be required to synthesize 
Ppt de novo from pantoate and beta-alanine, and so PptH may operate a CoA salvage path. I 
designed CRISPRi ATc-regulated knockdowns of two essential enzymes in the synthesis of Ppt 
to test for synthetic lethality in PptH LOF mutant cells, which would indicate the role of PptH in 
a CoA salvage pathway. These enzymes were pantothenate B (panB) and pantothenate C (panC), 
which are essential enzymes involved in synthesizing pantothenate in the first steps of the CoA 
biosynthesis pathway. 
Because the function of PptH is not fully characterized, I aimed to additionally find the 
binding partners, modifications, and substrates of PptT and PptH. Because PptT and PptH are 
encoded for by adjacent genes in the same operon, I hypothesized that they may be binding 
partners because they are co-transcribed. Their relationship within the same pathway means that 
their interaction is possible, although this interaction may be transient. Co-immunoprecipitations 
(Co-IPs) were conducted to detect putative binding interactions between the two proteins. Prior 
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to conducting Co-IPs, protein detection methods were optimized through determining antibody 
detection limits, western blotting, and antibody purification protocols.  
 
Materials and Methods 
Strains of Msm: M. smegmatis mc2155 WT,  
M. smegmatis mc2155 D161E, Y97D, -AA23-25, H246N} these are all putative LOF PptH 
mutants resistant to 8918.  
Sequences of WT PptH and putative LOF mutant PptH are shown in Fig. S1.  
Strains of Mtb: M. tuberculosis H37Rv, rv2795c knockout (published in Ballinger et al., 2019), 
complement (unpublished), H246N (unpublished) 
Growth media:  
Liquid: Middlebrook 7H9 complete: contains tyloxapol, glycerol and ADN (NaCl, Albumin 
Fraction V, Dextrose) 
Solid: Middlebrook 7H11, glycerol and Middlebrook OADC Enrichment (Oleic acid, Albumin 
Fraction V, Dextrose, and Catalase)  
8918 MIC Assay: 
Msm strains were grown to log phase in 7H9 and diluted to an OD600 of 0.1 in 7H9. 200 µL of 
culture were added to each well of a 96-well plate, and 2 µL of 8918 was added to each well in a 
2-fold dose response. Moxifloxacin was used as a control in the same method as above, with 2-
fold dose response dilutions across the plate from 1 ng/ml to 1 µg/ml. The OD600 of the plate 
was read after 2 days of incubation at 37°C. Results are shown in Fig S2.  
Confirmation of mutations in rv2795c: Genomic DNA was extracted from Msm strains and 
rv2795c was amplified using primers flanking the gene (provided in Table 1).  Polymerase chain 
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reaction (PCR) products were run on agarose gels, gel purified, and sent for sequencing to 
confirm mutations. Sequences were analyzed using the ExPASY and Multalin programs and 
results are shown in Fig. S1.  




3’ end of 
rv2795c 
5’CTGGACGGTTATCCGTTCGAG3’ 5’CGGCAGAACCAGGGAAAGCAG3’ 
Table 1. Primers for sequencing rv2795c mutations. Primers used to sequence Msm putative 
PptH LOF mutants and the WT strain were designed to contain about fifty percent G-C content.  
 
Structural modeling of PptH mutants: Phyre and PyMol computer programs were used to 
predict the location of mutations in relation to the active site. Surface cavity detection was set to 
a radius of 4 solvent radii.  
Growth curves: Msm cultures were grown to log phase in 7H9 and diluted to an OD600 of 0.1 
in 7H9. 200µl of culture at an OD600 of 0.1 was loaded into each well of a 96-well plate to 
begin. Data was collected with a Spark machine. Machine conditions were shaking at 27°C, with 
an OD600 measurement taken automatically every hour for 48 hours. The OD measurement for 
each well was the average of five, one in each quadrant of the well and one in the center. 
Chemical Stress Tests: For all chemical stress treatments, experiments were performed in 
duplicate and 7H9 was used as a control for the chemical unless otherwise indicated. OD was 
read using a spectrophotometer. Msm WT, D161E, Y97D, and –AA23-25 were used for each 
test and technical replicates of each sample were made in triplicate. For all tests that involved 
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plating, an input cell count was obtained by removing culture aliquots before the chemical was 
first added on Day 0, diluting serially in PBS, and plating on 7H11. 
Phosphate buffered saline (PBS) PBS-1% tyloxapol treatment of Msm strains, and Msm WT 
with 3 µM 8918: Cells were grown in 7H9 in 50 ml polystyrene tubes to log phase, pelleted and 
washed twice in PBS-1% tyloxapol before being resuspended to an OD600 of 0.1 in PBS-1% 
tyloxapol. Cultures were shaken for 48 hours at 37°C, then diluted serially in ten-fold and spot-
plated on 7H11 growth media in triplicate. 10 µl of culture was plated for each spot. Cultures 
were shaken for 6 more days at 37°C, and were then diluted serially and plated on 7H11 growth 
media in the same method. Plates were incubated for 2 days at 37°C, after which colonies were 
counted.  
Acidified sodium nitrite (3 mM and 6 mM) treatment of Msm strains and Msm WT with 3 µM 
8918 with either 3 mM or 6 mM NaNO2 diluted from a 100 mM stock of pH 4. Acidified 7H9 at 
pH 5.5 functioned as a control for the effects of sodium nitrite. Cells were grown in 7H9 in 50 ml 
polystyrene tubes to log phase, pelleted and washed twice in PBS-1% tyloxapol before being 
resuspended in 3 mM or 6 mM NaNO2 or pH 5.5 7H9 in 96 well plates with a starting OD600 of 
0.1. Cultures were incubated for 5 days at 37°C, diluted serially in PBS, and then plated on 
7H11. Plates were incubated for 2 days at 37°C, and then colonies were counted. The duration of 
time for exposure to and recommended concentrations of NaNO2 for experimental use were 
detailed previously (Darwin & Nathan, 2005).  
Osmotic treatment of Msm strains and Msm WT with 3 µM 8918 through exposure to water or 
0.5 M NaCl: Cells were grown in 7H9 in 50 ml polystyrene tubes to log phase, pelleted and 
washed twice in PBS-1% tyloxapol before being resuspended in water or 0.5 M NaCl to an 
OD580 of 0.1. Cultures were shaken for 4 hours at 37°C, then diluted serially and plated on 
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7H11 growth media. Plates were incubated for 2 days at 37°C, and then colonies were counted. 
Duration of exposure as well as experimental chemical concentrations were adapted from 
(Gebhard, Humpel, Mclellan & Cook, 2008).  
SDS liquid treatment of Msm strains and Msm WT with 3 µM 8918 strains: Cells were grown 
in 7H9 in 50 ml polystyrene tubes to log phase, pelleted and washed twice in PBS-1% tyloxapol 
before being resuspended in 0.5% or 0.05% SDS. Cultures were shaken for 4 hours at 37°C, then 
diluted serially and plated on 7H11 growth media. Plates were incubated for 2 days at 37°C, and 
then colonies were counted. Experimental chemical concentrations and duration of chemical 
exposure time were found in (White et al., 2010; Manganelli, Voskuil, Schoolnik & Smith, 
2001).  
SDS stress in plates:  Msm cells were grown in 7H9 in 50 ml polystyrene tubes to log phase, 
pelleted and washed twice in PBS 1% tyloxapol, then resuspended in PBS to an OD580 of 0.1. 
Cultures were serially diluted in PBS and then plated on 7H11 plates containing 0.00375%, 
0.005%, or 0.0075% SDS. Plates were incubated for 2 days at 37°C, and then colonies were 
counted. This alternative SDS exposure experimental protocol was adapted from (Daugherty, 
Powers, Standley, Kim & Purdy, 2011).   
Lysozyme MIC for Msm strains in 96-well plates: Cells were grown in 7H9 in 50 ml 
polystyrene tubes to log phase, pelleted and washed twice in PBS-1% tyloxapol. 200 µl of 
OD600 0.02 was added to each well in a 96-well plate. A drug plate was created with lysozyme 
diluted in triplicate two-fold across the plate in 7H9, starting at a concentration of 40 mg/ml, 
diluted down to 0.156 mg/ml. Moxifloxacin diluted in DMSO in triplicate was used as a control, 
with two fold dilutions across the plate from 3 µg/ml to 0.01 µg/ml. 2 µl from each drug well 
was diluted 1:100 into each well containing culture and plates were incubated for 3 days at 37°C. 
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OD was read with a spectrophotometer. Suggested concentrations for lysozyme were retrieved 
from (Flores, Parsons & Pavelka, 2005). 
EtBr uptake assay to measure cell membrane permeability: Msm cells were grown to log phase 
in 7H9, washed in 1X PBS/Tween80, and diluted to an OD600 of 0.8 with 0.4% glucose. 100 µl 
of cells at an OD600 of 0.4 was added in triplicate to a 96-well plate on ice. 8 µg/ml of EtBr in 
1X PBS/Tween80-0.4% glucose was prepared and added in 100 µl aliquots to the culture wells, 
to achieve a final concentration of 4 µg/ml EtBr. An excitation value of 530 nm and emission 
value of 590 nm were used to detect fluorescence, which was read every minute for one hour. 1X 
PBS/Tween80-0.4% glucose was used as a control. A SpectraMax microplate reader was used to 
measure OD. This protocol was adapted from Kristin Burns-Huang.  
CRISPRi cloning was utilized to generate two pantothenate B (panB) and pantothenate C 
(panC) knockdown targeting strains in Msm WT and strains D161E and -AA23-25. These are 
two essential enzymes in the synthesis of Ppt. The protospacer adjacent motif (PAM) sequences 
chosen for the knockdowns were of varying strengths, with panC1 possessing the greatest fold 
knockdown ability described, panB1 at half of this level, and panC2 and panB2 at 43% and 35% 
of the recorded knockdown ability of panB1, respectively (Table 2). A non-targeting control 
sequence was also created for each enzyme to use as a negative control. An anhydrotetracycline 
(ATc)-inducible sgRNA was used to prevent transcription of these enzymes in the presence of 
ATc. The Msm CRISPRi plasmid backbone pLJR692 was used, which carries a kanamycin 
resistance cassette (Rock, 2017).   
The pLJR692 plasmid was digested with restriction endonuclease BsmBI for five hours at 55°C. 
The digested product was run on a 0.75% agarose gel containing SYBR green, and gel purified 
with a Qiagen kit. The CRISPRi primers were annealed at 95°C for two minutes, and then the 
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temperature was decreased to 25°C at a rate of 0.1°C per second. The digested plasmid and 
annealed primers were ligated at room temperature overnight and a control reaction lacking 
primers was also set up. The ligated CRISPRi backbone mixture was used to transform Mach1 E. 
coli cells, and the cells were plated on LB-agar containing 50 µg/ml kanamycin (Kan50). Select 
colonies were inoculated into LB- Kan50 overnight, mini-prepped, and then sequenced. The 
sequencing results confirmed the presence of the plasmid, which was used to transform 
electrocompetent Msm strains WT, D161E and -AA23-25. The Msm cultures were grown on 
7H11 plates and transformants were used for subsequent experiments to test knockdown levels 
achieved. Msm transformants chosen were grown in 25 µg/ml kanamycin for any further use in 




Forward (-) and Reverse (+) Primers PAM sequence PAM 
strength 
panB  1 - 5’ GGGAGCGTCGCCGCGGCCCTGCAC 3’ 
+ 5’ AAACGTGCAGGGCCGCGGCGACGC 3’  
 + 5’ TTTCCGC 3’ 
- 5’ GCGGAAA 3’ 
110.5 
2  - 5’ GGGAGAGTCACCCACCAGGAGCA 3’  
+ 5’ AAACTGCTCCTGGTGGGTGACTC 3’  
+ 5’ ATTCCGG 3’  
- 5’ CCGGAAT 3’ 
47.3 
panC  1 -5’ GGGAGCGCGGTCGGGGCGAACGAT 3’ 
+5’ AACATCGTTCGCCCCGAVCGCGC 3’ 
+ 5’CTTCTCG 3’ 
- 5’CGAGAAG 3’ 
216.7 
2 - 5’ GGGAACCCGCGAAATGGCCTGGGCG 3’ 
+ 5’ AAACCGCCCAGGCCATTTCGCGGGT 3’ 
+ 5’ TTCCTCG 3’ 
- 5’ CGACCAA 3’ 
38.5 
Table 2. Primers and PAM sequences used for CRISPRi design. Two primers were designed 
for each panB and panC construct and PAM sequences were designed to be of varying strengths. 
PAM strength was previously measured as fold knockdown standardized against a Renilla target. 
15	
	
216.7 is the highest recorded knockdown value and 38.5 is the lowest recommended value for 
CRISPRi (Rock et al., 2017).   
 
Fig. 3. Plasmid Vector Backbone PLJR962 (reproduced from Rock, 2017). The Msm plasmid 
vector PLJR962 was used for CRISPRi cloning to generate panB and panC knockdown strains. 
This Tet-Off plasmid encodes an sgRNA that causes ATc-inducible repression of the target gene, 
as it is under the control of a promoter that activates expression in the absence of ATc. The 
sgRNA and dCas9 enzyme are induced with ATc to repress expression of panB and panC. This 
plasmid also has a kanamycin resistance cassette.  
 
ATc synthetic lethality screening CFU assay: Msm WT and Msm D161E and -AA23-25 panB 
and panC knockdowns (both experimental and control strains) were grown in 7H9 supplemented 
16	
	
with 100 ng/mL ATc for one day, then plated on 7H11 containing 100 ng/ml ATc. Plates were 
incubated for two days at 37°C, and then colonies were counted. A Tet-ON DnaK knockdown 
strain that has active transcription in the presence of ATc was used to confirm that the ATc stock 
was not degraded (strain shared from Fay & Glickman, 2014). This experiment was repeated.  
An ATc dose response was tested in a 96-well-plate: Msm WT, D161E and -AA23-25 of OD580 
of 0.001 and 0.01 Msm were inoculated into a plate serially diluted with 2 to 100 ng/ml ATc and 
incubated at 37 °C for two days, then at 22°C for one day. The OD of the plates was read at this 
time.   
An ATc disk diffusion assay was conducted, testing concentrations of 0, 0.5 µg, 2.5 µg, and 5 µg 
ATc. 150 µl of 0.1 OD580 Msm WT, D161E and -AA23-25 pan- knockdown strains were plated 
on 7H11 or 7H11 supplemented with 30 µg/ml pantothenate. Plates were incubated at 37 °C for 
two days and zones of inhibition (ZOI) for each plate were recorded at that time. Plates were 
then stored at room temperature for three days, and then 4°C for one day before images were 
taken of each plate.  
 
Binding Partners of PptT and PptH 
Strains used for western blots and IPs:  Mtb whole cell lysates (WT, pptH knockout (k/o), 
pptH complement (comp), H246N PptH putative LOF point mutant, and Msm whole cell lysates 
(overexpressing (o/e) mutant pptH H246N, WT, and pptH k/o) and Schnappinger Mtb PptT 
knockdown (kd) strain). 
Limit of detection of PptH and PptT antibodies: His-tagged PptT was purified by John 
Mosior from Texas A&M University and truncated PptH was purified by Elaine Ballinger of 
Weill Cornell Graduate School of Medical Sciences. PptT peptide antibody was raised against a 
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synthetic peptide based on a sequence near the N-terminus of the protein, and an antibody was 
also raised against the full PptH protein. Both antibodies were from rabbit and generated at New 
England Peptide. Two-fold dilutions of PptT were used, ranging from 39 ng to 10 µg. The 
western blot was blocked with the primary antibody overnight in a 1:500 dilution in 3% milk (in 
Tris-buffered saline-Tween (TBST) buffer), and then an anti-rabbit secondary antibody in a 
1:10,000 dilution in 3% milk for one hour. Thermo-Fisher SuperSignal West Femto Maximum 
Sensitivity Substrate solution was used to develop the blot.  
Mtb Lysate Preparation (conducted by Kristin Burns-Huang): Strains were inoculated into 
25 ml of 7H9 and OD was monitored over the course of a week. When cultures reached log 
phase, OD was recorded for each and 20 OD580 units were collected for each strain. Cells were 
harvested and washed in 1X PBS/Tween80. 400 µl of 50 mM Tris HCl/ 100 mM NaCl/ 10% 
glycerol/ 2 mM EDTA was added to each sample. Samples were bead-beated for 30 seconds 
three times, and placed on ice for two minutes in between each beating. 120 µl of supernatant 
was removed for each sample and 40 µl of 4X sample buffer was added to each. Samples were 
boiled for ten minutes and then placed on ice for immediate use.  
PptT western blot using anti-PptT peptide and PptH western blot using anti-PptH peptide 
in Mtb whole cell lysates: The western blot was blocked overnight in 3% milk (in TBST 
buffer), then blocked with the primary antibody overnight in a 1:500 dilution in 3% milk, and 
then an anti-rabbit secondary antibody in a 1:10,000 dilution in 3% milk for one hour. Thermo-
Fisher SuperSignal West Femto Maximum Sensitivity Substrate solution was used to develop the 
blot.  
IP of PptH: Mtb whole cell lysates used with the PptH peptide antibody.  
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IP of PptT: Mtb whole cell lysates were used with the histidine tag antibody. Lysates were 
incubated with 400 µg PptT for 1 hour before protein A/G beads were added. The his-antibody 
was used to IP and blot for PptT.  
Protocol for all IPs, adapted from Kristin Burns-Huang: 30 µl of lysate sample was aliquoted 
out for later use. Pierce Protein A/G Magnetic Beads were washed in PBS and protease inhibitor 
and 30 µl was added to the remaining 130 µl of lysate solution. The sample was stored at 4°C, 
rotating, for one hour. Beads were removed and 30 µl of sample was removed for later use. 
Antibody was added in a 1:100 dilution and the sample was stored at 4°C, rotating, overnight. 25 
µl of magnetic beads were pre-washed in PBS, protease inhibitor, 4% glycerol and 0.05% of 
surfactant Triton X-100. Samples were incubated at 4°C, rotating, for one hour. Beads were 
removed and 30 µl of sample was removed for later use.  The beads were washed with 500 µl of 
PBS, protease inhibitor, 4% glycerol and 0.05% Triton X-100 three times. 30 µl of sample was 
removed from the first wash for later use. PBS was used to elute protein from a third of the 
beads. 100 µL of 0.1 M glycine at pH 2.5 was added to the remaining beads. The beads were 
rotated for 10 minutes at room temperature. The supernatant was removed and 15 µl of 1 M Tris 
hydrochloride at pH 8 was added to neutralize the solution. Sample buffer was added and 
samples were boiled for ten minutes before being run on an SDS page gel.  
A semi-dry transfer method was used to transfer protein bands onto a blot. The western blot was 
blocked overnight in 3% milk in TBST buffer, then blocked with the primary antibody overnight 
in a 1:500 dilution in 3% milk, and then an anti-rabbit secondary antibody in a 1:10,000 dilution 
in 3% milk for one hour. Thermo-Fisher SuperSignal West Femto Maximum Sensitivity 
Substrate solution was used to develop the blot. 
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Co-IP of PptT and PptH: The previous procedure was followed, with the same samples. The 
his-antibody was used to IP for PptT and the PptH peptide antibody was used to blot for PptH. 
The PptH peptide antibody was used to IP for PptH with the His-antibody to blot for PptT.  
Statistical analysis and generation of figures: Figures with chemical structures were designed 
using ChemDraw computer software version 18.0. Graphs were generated using GraphPad Prism 
Version 7. Comparison of experimental groups was conducted by analysis of variance (ANOVA) 
using JMP statistical software from SAS (JMP®, Version 14. SAS Institute Inc., Cary, NC, 
1989-2019.)  
 
Results and Discussion  
Before testing the Msm strains for chemical stress phenotypes, I first confirmed that the 
mutant Msm strains were all resistant to 8918. The MIC for 8918 on WT Msm was found to be 
0.7 µM, as shown in Fig. S2A. The inhibitor compound displayed significant inhibition of 
growth of the mutant strains only above 20 µM. In Fig. S2B, moxifloxacin was used as a control 
because Msm is known to be susceptible to this compound. The MIC for the WT and mutant 
Msm strains with moxifloxacin was shown to be equivalent, at 0.3 µg/mL.  
The control PCR results from each of the mutant strains and the WT in Fig. S3 
demonstrate that pptH is present in each strain, at its expected size. It was necessary to confirm 
the presence of pptH in the mutant strains before chemical testing, to show that the gene was 
present but not functional. The size of the gene rv2795c was found to be about 960 base pairs. In 
the PCR amplification gel image in Fig. S3, it measures about 1050 bp because of the addition of 
a 90 bp primer. Only Msm WT and Msm –AA23-25 are pictured, but the rv2795c fragment was 




Fig. 4.  Mutant PptH protein structure predictions. Proteins were modelled using Phyre and 
PyMOL. (A) Sites of the three mutant protein residues are labelled on the WT PptH structure for 
understanding proximity to the enzyme active site, as all mutated residues are in the vicinity of 
the active site of the protein. (B-E) Individual mutant predicted structures are shown with each 
specific amino acid mutation labeled below each structure. The rainbow coloring depicts 
distance along the residue sequence, with the N-terminus colored as blue, progressing through 
the colors of the rainbow to red, for the C-terminus. The structures have been arranged to be in 













Predicted ligand binding site for PptH is shown by the orange phosphorus atoms. This region 
denotes the active site of the enzyme. This structure was generated through PyMOL surface 
cavity detection with a radius of 4 solvent radii.  
 
The mutant protein structure predictions produced from Phyre and PyMOL shown in Fig. 
4 display particular variation in the C-terminal folding patterns. It should be noted that the 
modeling program is limited in its ability to predict fully accurate structures. In Fig. 4B-E, the 
mutant protein structures are shown to be similar to that of the WT, although slight modifications 
do exist and are impactful in the active site of the enzyme, as they are deleterious to the function 
of the enzyme. The D161E mutant C-terminus region appears most different from the others, 
which is an interesting consideration as the mutation is a conserved change (both aspartic acid 
and glutamic acid are negatively charged amino acids). The location of mutated residues in Fig. 
4A shown to be at the predicted enzyme active site is expected, as these mutations are believed 
to severely impact the function of the enzyme and this is the most functionally important part of 
the enzyme, which is shown with its predicted bound ligand in Fig. 4F. 
Under the same growth conditions, the mutant strains did not have a growth phenotype 
different than the WT strain, although this was only tested at 27°C and 37°C. The growth rate 
curve of the mutant strains presented were found to be the same as the WT strain at 27°C with 
shaking growth conditions, and a stationary phase value of OD600 of 0.9 was found, as shown in 
Fig. S4. Similar results to those seen in Fig. S4 were obtained in repeat growth curve 
experiments at 37°C, although clumping of the cells in the 96 well plates was often experienced 
at this higher temperature. Although all strains reached a greater OD at this higher temperature, 
there were no significant differences in growth rate and final OD between WT and PptH putative 
22	
	
LOF mutants. A possible difference in cold growth phenotype between the mutants and WT was 
not explored, nor was a difference in stationary phase phenotypes, as growth was only studied 
for 48 hours. 
Tests to determine the conditions under which PptH is essential: Chemical stresses  
Mtb lives in the host in a state of acidic pH, low oxygen, poor nutrient availability, and 
abundant reactive oxygen and nitrogen species (Ehrt & Schnappinger, 2009). To simulate this 
model, I used phosphate-buffered saline (PBS) to create a nutrient starvation in vitro, acidified 
sodium nitrite as a source of nitric oxide and reactive nitrogen and oxygen intermediates, and 
lysozyme to replicate native hydrolytic lysosomes that break down peptidoglycan. To target the 
cell wall specifically, I chose sodium dodecyl sulfate (SDS), an anionic detergent that denatures 
proteins and disrupts cellular membranes (“Sodium Dodecyl Sulfate”). I also used sodium 
chloride and water to create osmotic stress (White, He, Penoske, Twining & Zahrt, 2010). An 
ethidium bromide (EtBr) uptake assay was selected to gauge changes in cell wall integrity, as it 
is a common assay to measure cell wall permeability. For most chemical stress tests, Msm WT in 
the presence of a sublethal concentration of 0.3 µM of 8918 (half of the WT minimum inhibitory 
concentration (MIC) value) was used to indicate that the compound was effective and explore if 








Chemical Mutant Phenotype Decreased survival of the WT  
PBS No No 
Acidified NaNO2 No Yes 
Osmotic No No 
SDS Yes Yes 
Lysozyme No Yes 
EtBr Yes Yes 
Table 3. Summary of Msm responses to chemical stress tests. Select chemicals were used to 
test for the conditions under which functional PptH is essential.  
 
Msm PptH putative LOF mutants respond to PBS with similar survival phenotypes as WT. 
There was no significant difference between the survival of WT and PptH putative LOF mutants 
in the presence of PBS-1% tyloxapol, which was used to simulate a nutrient starvation model. 
Less survival occurred after 8 days in PBS as opposed to after 48 hours, but this difference was 
not significant compared to the input survival value, the number of surviving cells after 48 hours, 
or amongst strains. PBS did not cause a stressed survival phenotype. This result was found again 
when the test was repeated under the same experimental conditions.  
Msm PptH putative LOF mutants respond to acidified sodium nitrite with similar survival 
phenotypes as WT. No significant difference existed between the survival of WT and putative 
PptH LOF mutants in the presence of acidified sodium nitrite after 5 days. There was not a 
significant difference in survival between cells exposed to 3 mM NaNO2 versus 6 mM NaNO2. 
NaNO2 was shown to hinder survival, by about a log more than cells in the acidified control 
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media. Only for the WT sample did cells exposed to NaNO2 have greater survival than those in 
acidified 7H9. About a half log of killing was observed in Msm WT in 3 µM of 8918. 
Msm PptH putative LOF mutants respond to osmotic stress with similar survival 
phenotypes as WT. There was no significant difference in survival between mutant strains and 
the WT under any of the tested conditions. An average of a half log decrease in survival occurred 
in the presence of 0.5M NaCl, but there was no significant decrease in survival in the presence of 
water compared to survival in the control solution of 7H9. For Msm WT in 3 µM of 8918, almost 
one log of killing occurred. Water did not cause a stressed survival phenotype.  
The chemical stresses of PBS, NaNO2, lysozyme, NaCl and water did not induce a 
significant difference in survival between the mutant and WT strains. Exposure to PBS did not 
result in decreased cell survival, nor did exposure to water. NaCl was demonstrated to induce a 
higher degree of killing than water, and both allowed less Msm survival than the control 7H9 
solution, although this stressed result was not significant (Table 3). PBS and osmotic stress tests 
may not have been harsh enough tests to elicit a phenotype from either mutant or WT strains, as 
opposed to other tests where both strains were affected. NaNO2 was shown to stress cells 
independently of acidity. The MIC value I found for lysozyme was inconsistent with previous 
reports of lysozyme MIC assays on Msm, as I found the MIC for all strains to be about 50 
µg/mL, which is 40 times lower than the reported value of 2 mg/mL for a WT PM759 Msm 
strain. The mutant strains and WT responded similarly to treatment with lysozyme. This 
discrepancy may be due to the use of a different Msm strain. The transposon mutant lysozyme 
MIC values found in this previous study ranged from 31.25- to 250 µg/mL, which is consistent 
with the value that I found (Flores et al., 2005).  
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To demonstrate that phenotypes seen during a chemical stress test are specific to PptH 
and not due to a mutation at another site in the genome, the chemical stress phenotypes should be 
confirmed with complemented Msm strains. This could be done by recombination-mediated 
genetic engineering of the WT allele back into the mutant strains to determine if the stressed 
phenotype is reversible, or by expressing WT in the mutant background to complement.  








C.               
   
 
Fig. 5. Response of PptH putative LOF mutants to SDS stress. (A) Mutant cells are more 
susceptible to SDS stress than WT cells when plated on 7H11 agar containing SDS. Cell survival 
was quantified for each strain from spot dilutions exposed to different concentrations of SDS. 
The difference in the survival response to 0.0075% SDS between WT and mutant strains was 
shown to be statistically significant (P< 0.0001) by a comparison of least squares means with a 
Tukey correction. Samples not denoted by the same letter (A and B) are significantly different. 
Error bars show standard deviation from the mean (N=3). Further statistical testing is shown in 
Fig. S5. (B) The spot plating of the WT versus strain -AA23-25 for an SDS-treated and non-
treated control 7H11 agar plate are shown above. Red numbering indicates ten-fold dilution 
value. (C) Mutants and WT Msm similarly respond to SDS in liquid cultures. Control groups 
lacked SDS but received the same treatment conditions as the SDS group. Treatment with SDS 
was shown by a comparison of least squares means with a Tukey correction to have a statistically 
significant effect on growth (P<0 .0001). Differences in survival between strains were not 
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statistically significant. Error bars show standard deviation from the mean (N=3). Further 
statistical analysis is shown in Fig. S6.  
Discussion of SDS stress test results  
When plated on 7H11 agar containing 0.0075% SDS, PptH putative LOF mutants had 
lower survival rates than the WT. In preliminary testing, D161E was most susceptible to SDS, 
followed by Y97D, and then -AA23-25. In this test, the WT survived to a degree of one log 
greater in 0.0075% SDS than -AA23-25. Although there were slight differences in survival rates 
amongst the mutants in this initial test, these results overall support the results shown in Fig. 5A 
that the mutant strains had significantly lower survival than the WT. Fig. 5A shows discrepancies 
in growth between strains at 0.005% and 0.0075% SDS, with all mutant strains surviving one log 
less than the WT. These results were repeatable. 0.005% SDS in 7H11 does not cause significant 
stress to Msm survival. In the second plate shown in Fig. 5B, a ten-fold dilution of cells 
produced several colonies for the WT strain, but no colonies for the mutant strain. Fig. 5C shows 
a 1.5 log reduction in growth among mutants and the WT compared to the untreated control 
when exposed to 0.05% SDS for 4 hours, but the mutants did not respond differently to SDS than 
the WT in liquid cultures.  
The investigation of the conditions in which PptH is essential through chemical stress 
tests yield results that indicate PptH may be involved in cell wall integrity. The phenotypes 
produced from each of the stress tests were not consistent, but the SDS tests suggest that the lack 
of functional PptH produces cells with a defective cell wall or an impaired cell wall repair 
process as measured by lowered cell counts in chemical tests. The decreased cell survival 
compared to WT Msm observed in the mutants in 0.0075% SDS in 7H11 plates is significant 
across all mutant strains (Fig. 5A). SDS is a detergent that breaks down lipids and interactions 
28	
	
between proteins; its negative charge linearizes proteins and gives them a uniform anionic 
charge. It is an established “cell-wall perturbing” agent, and decreased survival in the presence of 
SDS is attributable to a cell-wall defect (Vandal et al., 2008). Repetition of this experiment with 
the addition of 0.005% SDS in 7H11 revealed that this concentration is too low to produce a 
disparate growth phenotype for mutant strains, and provides a minimum concentration to explore 
a dose response spectrum to SDS stress in Msm.    
Interestingly, this same stressed survival phenotype was not observed when SDS was 
introduced in liquid culture (Fig. 5C). This discrepancy in response to SDS could be due to 
oxidative effects on cells at air-agar boundaries as experienced on plates as opposed to a liquid 
culture, where levels of oxygen are lower. Other possible explanations include differences in a 
molecular space-filling model of atoms due to different states of matter that allow for increased 
cellular interaction and signaling in a liquid culture, that may reduce susceptibility to stresses.  
 
Fig. 6. EtBr uptake assay revealed that PptH putative LOF mutants emit greater 
fluorescence than the WT. The difference in RFU between mutant and WT experimental strains 
after 60 minutes was not statistically significant. A greater RFU value is indicative of increased 
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cell wall and membrane permeability. Error bars show standard deviation from the mean (N=3). 
Further statistical testing is shown in Fig. S7. 
 
In Fig. 6, D161E had the greatest relative fluorescence of 200 RFU (Relative 
Fluorescence Units) after one hour, followed by Y97D with 160 RFU. Strain  -AA23-25 and 
Msm WT had a similar fluorescence value of 130 RFU after one hour. This result may be 
indicative of the involvement of PptH in cell wall integrity, through the increased fluorescence of 
mutant samples. EtBr uptake assays are used to measure cell wall and membrane permeability, as 
the intercalating agent EtBr fluoresces at a greater level when taken up by and bound to nucleic 
acids in bacteria (Danilchanka, Mailaender & Niederweis, 2008). D161E had the greatest 
fluorescence, indicating that it has a more permeable cell membrane than the other mutants and 
WT. The difference in fluorescence units between the WT sample measured about 75 RFU. 
These results support my hypothesis that PptH is involved in cell wall integrity, as along with the 
SDS stress test results, they imply that the absence of functional PptH confers a cell wall defect. 
This test was only conducted once and the inoculation order of samples in the 96-well plate did 
mirror the RFU results, which is a possible confounder of results. Repeating the assay with more 
replicates in a randomized order could correct for this possible error and is necessary to reveal if 








Testing for the Possible Role of PptH in a CoA Salvage Pathway 
 
 
Fig. 7. CRISPRi strain response to ATc in liquid media. The blue bars represent strains that 
were not exposed to ATc before plating. The red bars show strains grown in 100 ng/ml ATc in 
7H9 for one day before plating. The striped bars represent samples plated on 7H11 containing 
ATc. In strain names, “B1” and “C2” refer to the presence of a panB or panC CRISPRi targeting 
sequence. A Tet-ON DnaK knockdown strain was included to show the integrity of the ATc 
stock, and is expected to behave in a manner opposite to the other stains, as the presence of ATc 
should enhance its growth. Differences in the growth response within the –AA23-25 C2 strain, 
D161E B1 and C2 strains, and DnaK strain across treatment groups were statistically significant 
(P=0.0001), as shown through ANOVA F-test slicing. The difference in the growth response of 
the D161E control strain across treatments (P=0.0016) and of the –AA23-25 B1 strain across 
treatments (P=0.0005) was also significant. Specific samples denoted by an asterisk indicate 
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significant differences in growth response within a strain as compared to the control treatment of 
no ATc for that strain. This analysis was done through a Dunnett’s Multiple Comparisons test 
with the control (P<0.05) and highlights the samples that were shown to account for the 
significant differences seen through the F-test slicing. Error bars show standard deviation from 
the mean (N=3). Further statistical analysis is shown in Fig. S8. 
A.                                             B. 
   
 
Fig. 8. ATc Disk diffusion assay with CRISPRi panB/C constructs. (A) Disk diffusion assays 
were conducted on WT and deletion mutants with ATc at concentrations of 0, 0.5, 2.5, or 5 µg 
ATc and the diameter of the zone of inhibition was recorded for each. Differences in the ZOI 
diameters between strains were not significant and the inhibition response to 5 µg ATc for select 
strains is provided. (B) A novel “secondary ZOI” was observed in Msm strains containing a 
panB or panC knockdown sequence at all concentrations of ATc when plates were grown to 






Discussion of CRISPRi PanB/C constructs and experimental results  
Recent studies from collaborators of the Nathan laboratory have found that conditional 
knockdowns of pantothenate B (panB) and pantothenate C (panC) in Mtb are bacteriostatic, as 
CoA levels are depleted, and amino acid and cell wall biosynthesis is impaired (Evans et al., 
2016). These researchers generated their knock-down strains by replacing native promoters with 
a Tet-regulated promoter by single crossover homologous recombination. They hypothesized 
that genes expressed at low basal levels in Mtb may be more efficiently silenced by newer gene 
silencing tools such as Clustered Regularly Interspaced Short Palindromic Repeats interference 
(CRISPRi). Using PptH putative LOF mutants, I tested for synthetic lethality with ATc-
repressible Tet-Off panB and panC knockdown strains generated by CRISPRi, hypothesizing 
that PanB and PanC are non-essential if PptH is present and functional and that they are essential 
if PptH is not present and/or not functional. Growth discrepancies between WT and knockout 
strains would infer if PptH were essential in the absence of essential enzymes needed for Ppt 
synthesis (Evans et al., 2016).  
Mutant PptH LOF CRISPRi panB and panC knockdowns were exposed to ATc to induce 
gene knockdown, and were expected to grow less than WT strains if gene knockdown and 
synthetic lethality were occurring. Exposure to ATc prior to plating is necessary to knockdown 
PanB and PanC protein transcript levels to a level low enough to confer a growth defect. Msm 
D161E and -AA23-25 CRISPRi panB and panC knockdowns pre-treated with 100 ng/ml ATc in 
liquid media for one day exhibited half a log less CFU/ml than strains without a knockdown 
sequence or strains not pre-treated with ATc, as shown in Fig. 7. The presence or absence of ATc 
in the agar plate did not affect growth. DnaK experienced killing when deprived of ATc, which 
was expected with a Tet-On strain. Both WT strains possessing a panB/C targeting sequence or 
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control CRISPRi sequence showed no defect in the presence or absence of ATc, nor did mutant 
strains with the control CRISPRi sequences. Mutant strains with a panB/C targeting sequence 
exhibited significantly less growth when pre-treated with ATc. This experiment was conducted 
in triplicate, but when repeated, these findings varied slightly each time and were largely not 
reproducible. Fig. 7 is included to show the growth patterns of the CRISPRi knockdown strains 
in the presence of the specific ATc conditions shown, as determining if gene knockdown is 
occurring is a necessary precursor to determining if PptH is functioning in a CoA salvage 
pathway.  
Fig. 8A reveals that Msm strains do not respond differently to ATc through a disk 
diffusion assay. No true zone of inhibition (ZOI) formed from DMSO or 0.5µg ATc and similar 
ZOIs formed from 2.5 µg and 5 µg ATc. A small false ZOI formed around all disks containing 
ATc in response to the toxicity of the compound. The “secondary ZOI” observed in select 
samples in Fig. 8B was of the same diameter for samples in which it was present.  
Results from the CRISPRi cloning experiments do not reveal repeatable panB/C 
knockdown growth inhibition and suggest that neither PanB nor PanC levels were effectively 
lowered in the Msm cells. This is evidenced by the inability to replicate results shown in Fig. 7 
(which suggests that slight knockdown effects are observed in strains with a panB/C targeting 
sequence that had been pre-treated with ATc) through a repeat of CFU assays. This test indicated 
that mutant strains with a panB/C targeting sequence experienced greater growth knockdown 
effects than mutant control strains lacking the sequence. This difference based on the presence of 
a panB/C targeting sequence was not observed for WT strains. WT strains were expected to have 
a growth value similar to the mutant control strains, because they have a functional PptH and 
should not be experiencing synthetic lethality in the absence of PanB/C. For conclusions to be 
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drawn from the findings shown in Fig. 7, these results would have to be replicated at least two 
more times, and WT growth should be greater than mutant growth to indicate synthetic lethality. 
Results indicating differences in growth between mutant and WT knockdowns were not obtained 
by liquid growth assays to achieve dose responses in 96 well plates, or disk diffusion assays.  No 
dose response to ATc was achieved when conducted in 96-well plates with a starting Msm 
OD580 of 0.01 or 0.001. Disk diffusion assays with ATc yielded similar zones of inhibition of 
about 1 cm for all strains tested, as shown in Fig. 8A. There was no consistent growth response 
associated with ATc concentration for any strain in this test.  
Because evidence is not conclusive that panB and panC were successfully targeted and 
knocked down, no conclusions can be drawn from these experiments that a CoA salvage 
pathway does or does not exist. The DnaK Tet-On strain shown in Fig. 7 confirmed that the ATc 
stock was not degraded. The plasmid vector containing the knockdown sequence should have 
been retained in transformed Msm cells, as they were grown in the presence of kanamycin due to 
the kanamycin resistance cassette present in the plasmid. PanB/C levels may not have been 
knocked down because the PAM sequence was not strong enough or a sequence in the promoter 
should have been targeted instead of the region that I chose in the open reading frame. It has 
been previously reported that “each possible permissive PAM position variant may not be 
functional with all other variants,” and testing of each of the 24 variants can determine which 
works best (Rock et al., 2018, p. 5). Due to experimental material and time constraints, I tested 
four PAM sequences, but chose them to vary in their reported strengths, ensuring that one had 
maximum tested fold repression (Table 2). Rock reports a knockdown range of 2.7–216.7 fold 
(Rock, 2017). In a future repeat of this CRISPRi experiment, it may be necessary to test all 24 
variants to produce a successful knockdown strain.  
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To circumvent possible limitations to CRISPRi that are not fully explored, pan B/C could 
be knocked down in the future by single crossover homologous recombination. This method was 
used by Evans et al. in 2016 when exploring the efficacy of CoaBC as a bactericidal target. Other 
possibilities include that pan B/C is knocked down but does not confer a growth deficient 
phenotype. If this were the case, I could determine if knockdown is occurring by qRT-PCR, and 
if there is upregulation of panB, or panC in the mutants. If an antibody to Pan B/C were 
generated, a western blot of PptH in panB and panC knockdown strains in WT and the PptH 
putative LOF mutants could be performed. The next most logical step for this experiment is to 
conduct qRT-PCR to determine if gene knockdown is occurring. Possible flaws in my 
experimental design may have been a lack of optimization of the duration of the ATc depletion 
period. Strains were depleted for up to 3 days with ATc, but this may not have been a long 
enough time course. I selected this duration from normalizing it off of the standard ATc 
depletion time used in Mtb, and it was expected to be a long enough duration for Msm, based on 
the growth rate of Msm. Because the ATc growth inhibition experiments may have been 
conducted with strains in which PanB and PanC levels were not knocked down, synthetic 
lethality could not be tested for and no conclusions about the role of PptH in a synthetic lethality 
pathway can be made from these experiments.  
Fig. 8B depicts the formation of a “secondary ZOI” in plates that had been exposed to 
ATc, which was observed in strains possessing a knockdown sequence. This novel effect was 
noted after the cells had reached stationary phase, and the plates were stored at 4°C. This 
secondary zone had a lawn of cells that was thinner than the lawn on the rest of the plate, and the 
air-lawn surface was shiny and glossy in appearance. The zone was not seen in the control 
samples, plates lacking ATc, or plates that had been supplemented with 30 µg/ml pantothenate. 
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There is no mention of secondary ZOIs in previous literature, but it is possible that a phenotype 
emerged in the knockdown strains that was temperature sensitive or only appears during 
stationary phase. This hypothesis is a point of further exploration.  
















Fig. 9. PptH and PptT peptide antibody recognition. (A) Limit of Detection (LOD) of PptT 
peptide antibody. The western blot SDS-PAGE gel shows purified PptT diluted two-fold, 
decreasing in concentration from left to right. The PptT peptide antibody LOD on purified PptT 
from John Mosior of Texas A&M University was found to be 39 ng. The expected size of PptT 
is 24.7 kD, as observed in the blot. The LOD of the PptH full protein antibody was not readable 
due to degradation of the PptH protein purified by Elaine Ballinger. (B) This western blot of Mtb 
whole cell lysates using the PptT peptide antibody displays an intense band at 21kD, which is 
nearly 4 kD lower than expected for PptT. (C) PptT peptide antibody does not recognize PptT in 
Mtb whole cell lysates. This blot of Mtb whole cell lysate samples was produced by Curtis 
Engelhart of the Dirk Schnappinger Lab of Weill Cornell Medicine. The arrow points to a Tet-
ON PptT knockdown strain in the absence of ATc. (D) PptH peptide antibody recognizes PptH 
in Mtb and Msm whole cell lysates. The results of the western blot demonstrate that the PptH 
peptide antibody is not pure, but recognizes PptH. Samples shown above are Msm whole cell 
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lysates (left), followed by Mtb whole cell lysates (right). The red arrow denotes the PptH band at 
37 kD, which is the expected size. Contaminating band identities were not determined. 
 
A.      B. 
 
C.                 D. 
 
Fig. 10. PptT and PptH IP in Mtb whole cell lysates and are not shown to interact through 
co-IP. (A) The PptH peptide antibody is successful in detecting PptH when used for IPs, as PptH 
is eluted from Mtb whole cell lysates via acid in WT and pptH complemented samples, and not 
present in pptH knockout samples. (B) PptT is pulled down when added exogenously to lysate 
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samples and detected with a his-antibody. (C) PptH is not eluted in any sample, and is only 
present in the unbound original lysate sample. (D) This blot reveals PptT eluted in the WT and 
pptH knockout samples, but not the complemented sample, although it is present in the unbound 
original lysate fraction for all samples tested. The red arrows denote the expected size for PptH 
and PptT, at 37kd and 25 kd, respectively.  
  
PptT and PptH are Not Found to Interact Through Co-IPs  
 PptT and PptH were hypothesized to potentially physically interact because they act in 
the same pathway and are encoded next to each other in the same operon in multiple 
mycobacterial species. While these conditions do not mean that they necessarily interact with 
each other, this is a possibility. It is also possible that one of the proteins is modified post-
translationally so that it is inactivated and they do not oppose each other’s functions.  
The PptT peptide antibody failed to recognize PptT in Mtb whole cell lysates, as 
confirmed through the use of the Schnappinger laboratory PptT knockdown strain (Fig. 9C). The 
arrow showing the band at 20-21kD from the Tet-ON PptT knockdown strain in the absence of 
ATc should be fainter than it appears if the antibody is truly recognizing PptT, especially in 
comparison to the PptT knockdown strain in the presence of ATc. Possible reasons for why PptT 
is not recognizable include that the antibody is degraded, or modified at the epitope. The most 
likely explanation is that PptT is not present in great enough quantities natively in the cell to be 
recognized by this antibody, as it does have a LOD of 39 ng (Fig. 9A).  
The experiments involving protein blotting of PptT and PptH were restricted by available 
antibodies. For the PptH peptide antibody, the most antigenic region of the full protein that the 
antibody had been created from was not present in the truncated purified protein. This antibody 
40	
	
was also not clean, as shown in westerns detecting PptH seen in Fig. 9D. Attempts were made to 
purify the antibody using a carboxy-link column. The C-terminus of the peptide was modified to 
an amide. However, two glutamic acid residues exist in the peptide sequence that could 
potentially link to the carboxyl resin and enable purification of the antibody. An amino-link 
column could not be used due to the lack of a free primary amine in the peptide sequence. The 
peptide sequence also lacks any lysines and has an acylated N-terminus. Affinity purification of 
the antibody was not successful, likely because not enough peptide was bound to the column. 
One mg of peptide was available and this was used, but was also the lowest recommended 
peptide quantity to bind to the column.  
Because the antibody designed to the PptH peptide was not clean but recognizes PptH, it 
was used for the IP of PptH in Mtb whole cell lysates. It was found to effectively detect and 
allow IP of PptH, as confirmed by the pptH knockout sample (Fig. 10A). Purified PptT with a 
poly-histidine tag was added exogenously to lysates because a his-antibody was available to 
detect this protein. This experiment was conducted presuming that the exogenous PptT would 
interact with PptH in the same manner as native interactions may occur in the cell. Under these 
conditions, PptT was successfully immunoprecipitated, as it was present at its expected size in 
the acid elutions of all three samples. Before conducting co-IPs of PptH and PptT, it was 
necessary to confirm that each of these proteins successfully IP individually.  
Co-IPs of PptH and PptT did not indicate that the two proteins interact under the 
conditions tested. In Fig. 10C, PptH was not eluted by acid in any sample. Although Fig. 10D 
reveals PptT in the acid eluted WT sample, this PptT band would be present in the pptH 
complemented sample and absent from the pptH knockout sample if there was an interaction. 
Because PptT is faintly present in the knockout sample and absent from the complemented 
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sample, this proposed interaction between the two proteins is false. All experiments with the 
purified PptT were conducted under the assumption that the protein was functional. If the protein 
were not functional or degraded, it would likely not bind to PptH. It is possible that the two 
proteins do interact natively but this interaction was not revealed through the artificial method of 
exogenously adding PptT. Electrospray ionization mass-spectrometry data could be used to 
confirm that PptT and PptH are not binding partners, and find other binding partners and possible 
modifications of the proteins.  
Mass spectrometry was not conducted on my samples because the Weill Cornell 
Medicine Proteomics Core did not believe that major differences would be apparent between my 
co-IP samples. This was because I was not able to identify banding differences between my 
samples of WT, pptH complement, or pptH knockout by silver staining or coomassie staining 
(“Protocol for Silver Staining”). To obtain new samples for mass spectrometry, Kristin Burns-
Huang repeated the co-IP experiments with lysates from a larger volume of cells. She used 50 
mL Mtb, which is the maximum volume of culture normally used for this class of experiments. 
She attached the PptH antibody in serum form to the beads so it would be less likely to 
elute.  This was repeated, and PptH was not eluted either time. Some cross-reactive bands 
appeared when the blot was heated to elute, but this was not indicative of the presence of PptH. It 
is possible that the PptH antibody was not efficiently cross-linked to the beads, or that PptH is 
not consistently amenable to IP under these conditions.   
If PptH and PptT do interact, it is also possible that the interactions between them are 
more transient. If this were true, a small chemical cross-linker is often used to fix weaker 
interactions. However, the structures of PptT and PptH lack the ‘covalent handles’ necessary for 
this linkage. For this type of experiment, crosslinks normally form if the proteins are within a 
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few angstroms of each other, which implies that they may already be interacting. Pull-down 
assays could also be used to detail any interactions, as well as a bacterial two-hybrid system. For 
future assays, a purified PptH protein and peptide sample, as well as a PptT knockdown strain 
would lead to more clarity in results, and more flexibility in the design of experiments. In future 
tests, I would like to use the optimized western to see if protein expression varies in different 
growth stages or stress conditions, and co-IP under these conditions to see if they affect the 
interactions between PptT and PptH. I am also interested in exploring the other possible binding 
partners, modifications, and substrates of PptT and PptH in Msm and Mtb.  
 
Conclusion 
Overall, these experiments have established groundwork for future experiments to 
determine the role of PptH in the mycobacterial cell. My chemical stress testing results indicate 
that functional PptH may be required for complete cell wall integrity in Mycobacteria. 
Experiments with Coenzyme A metabolism leave many questions open and raise interesting 
considerations for future studies with bacterial CoA synthesis. Through co-IPs, PptH is not 
shown to interact with PptT, and I have proposed methods to confirm this in future experiments.  
These tests have provided insight into mycobacterial biology as well as a greater 
understanding of possible functions of PptH that may support its future efficacy as an Mtb drug 
target. This work further elucidates the characteristics of an enzyme of which the LOF is a novel 
record of antimicrobial resistance (Ballinger et al., 2019).  The Nathan laboratory is continuing 
to explore substrates of PptH, as well as its role in CoA salvage in Mtb, and desiccation. They 
have devoted more resources to studying PptH as interest in this enzyme has grown. This project 
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is a novel area of exploration in mycobacterial metabolism and virulence and is anticipated to 
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Fig. S1. Msm WT and PptH LOF mutant protein sequences derived from Multalin. The 
green arrows denote sites of mutation. These sequencing results confirmed the specific mutations 
present in the PptH putative LOF mutants. (A) Msm WT reference sequence. (B) Msm D161E 
mutant caused by a substitution of adenine for cytosine at 510bp. (C) Msm Y97D mutant caused 
by a substitution of guanine for thymine at 314 bp. (D) Msm -AA23-25 caused the deletion of 
bps 87-96, resulting in the loss of histidine, threonine, and glycine residues.  
 
A.       B. 
 
Fig. S2. MIC of Msm PptH LOF mutants to the PptT inhibitor compound 8918. (A)The 
MIC assay for 8918 is shown on the left and the MIC for 8918 on WT Msm was found to be 0.7 
µM. The inhibitor compound displayed inhibited growth of the mutant strains only above 20 µM.  
(B) The MIC of moxifloxacin was tested for as a control, shown on the right. The MIC for the 
WT and mutant Msm strains with moxifloxacin was equivalent, at 0.3 µg/mL. Error bars show 






A. Msm WT                                                B. Msm -AA23-25 
 
Fig. S3. PCR amplification of rv2795c in WT and deletion mutant samples. (A) Identical WT 
genomic DNA samples were loaded into each of five wells shown in the agarose gel. (B) 
Identical Msm –AA23-25 mutant genomic DNA was loaded into each of four wells shown. A 
band at 1000 bp is seen for each sample loaded in the two gels.  
 
 
Fig. S4. Mutant growth curves match that of the WT. The growth rate curve of the mutant 
strains presented were found to be the same as the WT strain at 27°C with shaking growth 
conditions. All values shown were collected in triplicate and optical density was measured every 
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hour, although readings for only every two hours are shown. Error bars show standard deviation 
from the mean (N=3).  
 
Supplementary Figures: Statistical Analyses  




Fig. S5. Two-way ANOVA for SDS stress response shown in Figure 7A. There was no 
statistically significant difference between Msm strains for input CFU counts, or growth 
response to 0.005% SDS. The difference in the growth response to 0.0075% SDS between WT 
and mutant strains was shown to be statistically significant (P< .0001) by a comparison of least 
squares means with a Tukey correction. Data were transformed into the natural log to fit the 





Fig. S6: Two-way ANOVA for SDS liquid stress test shown in Figure 7C. Treatment with 
SDS was shown by a comparison of least squares means with a Tukey correction to have a 
statistically significant effect on growth (P< .0001). Differences in growth between strains were 
not statistically significant. Data were transformed into the natural log to fit the assumptions of 
the model of normally distributed residuals with constant variance. 
  




Fig. S7. One-way ANOVA for the ethidium bromide uptake assay shown in Figure 8. The 
difference in RFU between mutant and WT experimental strains was not statistically significant. 
The fluorescence of the control strains was shown by a comparison of least squares means with a 
Tukey correction to be statistically significant compared to that of the experimental strains. Data 
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were transformed into the natural log to fit the assumptions of the model of normally distributed 






Fig. S8. Two-way ANOVA for the ATc Synthetic Lethality Screening shown in Figure 9. 
Significant effects of both treatment and strain were found for the majority of samples. By F-test 
slicing, the growth response of the deletion mutant control to different treatments and the 
response of all WT strains to different treatments was shown to be not significant. Differences in 
the growth response within the –AA23-25 C2 strain, D161E B1 and C2 strains, and DnaK strain 
across treatment groups were statistically significant (P=0.0001). The difference in the growth 
response of the D161E control strain across treatments (P=0.0016) and of the –AA23-25 B1 
strain across treatments (P=0.0005) was also significant. Significance was found by a 
comparison of least squares means with a Tukey correction. Treatment 1 consisted of a lack of 
pre-treatment with ATc, followed by plating on 7H11, Treatment 2 consisted of a lack of pre-
treatment with ATc, followed by plating on 7H11 with ATc, Treatment 3 consisted of pre-
treatment with ATc, followed by plating on 7H11, and Treatment 4 consisted of pre-treatment 
with ATc, followed by plating on 7H11 with ATc.  
